• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Examination of the in vivo effect of DIF, an inhibitor of G1 phase transition derived from Dictyostelium, as a new anti-cancer drug

Research Project

Project/Area Number 25460334
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field General pharmacology
Research InstitutionKyushu University

Principal Investigator

Takahashi Fumi  九州大学, 医学(系)研究科(研究院), 講師 (50274436)

Co-Investigator(Renkei-kenkyūsha) IGAWA KAZUNOBU  九州大学, 先導物質化学研究所, 助教 (80401529)
Project Period (FY) 2013-04-01 – 2016-03-31
Project Status Completed (Fiscal Year 2015)
Budget Amount *help
¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2015: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2014: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Keywords新規抗腫瘍薬 / 経口抗腫瘍薬 / 抗腫瘍薬 / GSK-3活性化 / Wnt / サイクリンD1 / G1期特異的 / Wntシグナル伝達系 / 橋渡し研究
Outline of Final Research Achievements

We reported that differentiation-inducing factor-1 (DIF-1), synthesized by Dictyostelium discoideum, inhibited proliferation of various tumor cell lines in vitro. However, it remained unexplored whether DIF-1 also inhibits tumor growth in vivo. In the present study, therefore, we examined in-vivo effects of DIF-1 using three cancer models: Mutyh-deficient mice with oxidative stress-induced intestinal tumors and nude mice xenografted with cancer cells, and lung metastasis model mice.
We found that oral administrated DIF-1 significantly suppressed tumor growth in all examined models.

Report

(4 results)
  • 2015 Annual Research Report   Final Research Report ( PDF )
  • 2014 Research-status Report
  • 2013 Research-status Report
  • Research Products

    (12 results)

All 2016 2015 2014 2013

All Journal Article (2 results) (of which Peer Reviewed: 2 results,  Open Access: 2 results,  Acknowledgement Compliant: 1 results) Presentation (10 results)

  • [Journal Article] Differentiation-inducing factor-3 inhibits intestinal tumor growth in vitro and in vivo.2015

    • Author(s)
      Kubokura N, Takahashi-Yanaga F, Arioka M, Yoshihara T, Igawa K, Tomooka K, Morimoto S, Nakatsu Y, Tsuzuki T, Nakabeppu Y, Matsumoto T, Kitazono T, Sasaguri T
    • Journal Title

      J Pharmacol Sci

      Volume: 127 Issue: 4 Pages: 446-455

    • DOI

      10.1016/j.jphs.2015.03.005

    • Related Report
      2015 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Differentiation-inducing factor-3 inhibits intestinal tumor growth in vitro and in vivo2015

    • Author(s)
      Kubokura N, Takaha-Yanaga F,Arioka M, Yoshihara T, Igawa K,Tomooka K, Morimoto S, Nakatsu Y, Tsuzuki T, Nakabeppu Y, MatsumotoT, Kitazono T and Sasaguri T
    • Journal Title

      J. Phramcol. Sci.

      Volume: in press

    • Related Report
      2014 Research-status Report
    • Peer Reviewed / Open Access / Acknowledgement Compliant
  • [Presentation] DIF-1 inhibits proliferation, infiltration and metastasis of malignant melanoma through GSK-3 activation2016

    • Author(s)
      有岡 将基、高橋 富美、笹栗 俊之
    • Organizer
      第89回 日本薬理学会年会
    • Place of Presentation
      横浜
    • Year and Date
      2016-03-09
    • Related Report
      2015 Annual Research Report
  • [Presentation] DIF-1はGSK-3βの活性化を介して悪性黒色腫に抗腫瘍効果をもたらす2015

    • Author(s)
      有岡 将基、高橋 富美、笹栗 俊之
    • Organizer
      第36回 日本臨床薬理学会学術総会
    • Place of Presentation
      東京
    • Year and Date
      2015-12-09
    • Related Report
      2015 Annual Research Report
  • [Presentation] DIF-1による悪性黒色腫の増殖・浸潤・転移の抑制2015

    • Author(s)
      有岡 将基、高橋 富美、笹栗 俊之
    • Organizer
      第68回 日本薬理学会西南部会
    • Place of Presentation
      下関
    • Year and Date
      2015-11-21
    • Related Report
      2015 Annual Research Report
  • [Presentation] DIF-1 exerts antitumor activity by suppressing the Wnt/β- catenin signaling pathway in melanoma cell line B16BL62015

    • Author(s)
      有岡 将基、高橋 富美、笹栗 俊之
    • Organizer
      第74回 日本癌学会学術総会
    • Place of Presentation
      名古屋
    • Year and Date
      2015-10-08
    • Related Report
      2015 Annual Research Report
  • [Presentation] Differentiation-inducing factor-3 inhibits intestinal tumor growth in vitro and in vivo2015

    • Author(s)
      久保倉 尚哉、高橋 富美、笹栗 俊之
    • Organizer
      第88回 日本薬理学会年会
    • Place of Presentation
      名古屋
    • Year and Date
      2015-03-18 – 2015-03-20
    • Related Report
      2014 Research-status Report
  • [Presentation] DIF-1 inhibits tumor growth in vivo reducing phosphorylation of GSK-3β and expressions of cyclin D1 and TCF7L22014

    • Author(s)
      高橋 富美、中津 可道、續 輝久、中別府 雄作、笹栗 俊之
    • Organizer
      第73回 日本癌学会学術総会
    • Place of Presentation
      横浜
    • Year and Date
      2014-09-25 – 2014-09-27
    • Related Report
      2014 Research-status Report
  • [Presentation] GSK‐3と創薬 ―がん、心不全、骨疾患の新規治療法を探る2014

    • Author(s)
      高橋 富美
    • Organizer
      第12回口腔医科学フロンティア
    • Place of Presentation
      東京
    • Related Report
      2013 Research-status Report
  • [Presentation] 担癌マウスを用いたDifferentiation-Inducing Factor-1の抗腫瘍作用の検討2013

    • Author(s)
      高橋 富美、笹栗 俊之
    • Organizer
      第34回 日本臨床薬理学会学術総会
    • Place of Presentation
      東京
    • Related Report
      2013 Research-status Report
  • [Presentation] 大腸癌細胞に対するDifferentiation-Inducing Factor-3の抗腫瘍効果2013

    • Author(s)
      久保倉 尚哉、高橋 富美、笹栗 俊之
    • Organizer
      第66回 日本薬理学会西南部会
    • Place of Presentation
      福岡
    • Related Report
      2013 Research-status Report
  • [Presentation] GSK-3β活性化物質DIF-1の担がんモデルマウスへの経口投与による抗腫瘍効果2013

    • Author(s)
      高橋 富美、笹栗 俊之
    • Organizer
      第72回 日本癌学会学術総会
    • Place of Presentation
      横浜
    • Related Report
      2013 Research-status Report

URL: 

Published: 2014-07-25   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi